PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma-Reference-Cited by-同舟云学术

PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma

Published:2019-08-28 Issue:11 Volume:8 Page:e1655362
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Billon Emilien¹,Finetti Pascal²,Bertucci Alexandre¹,Niccoli Patricia¹,Birnbaum Daniel²,Mamessier Emilie²,Bertucci François²¹³

Affiliation:

1. Département d’Oncologie Médicale, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Marseille, France

2. Laboratoire Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille Université, Marseille, France

3. Faculté de Médecine, Aix-Marseille Université, Marseille, France

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2019.1655362

Reference69 articles.

1. Epidemiological risk factors for adrenocortical carcinoma: A hospital‐based case–control study

2. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors

3. Adrenocortical Cancer Treatment

4. Management of Adrenocortical Carcinoma

5. Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Management of Advanced Adrenocortical Carcinoma;Current Treatment Options in Oncology;2024-07-27

2. Immune Checkpoint Molecules in Adrenocortical Carcinoma: Hope for Immunotherapy;The Journal of Clinical Endocrinology & Metabolism;2024-05-13

3. Expression and Prognostic Relevance of PD-1, PD-L1, and CTLA-4 Immune Checkpoints in Adrenocortical Carcinoma;The Journal of Clinical Endocrinology & Metabolism;2024-02-28

4. PDL1-Based Nomogram May Be of Potential Clinical Utility for Predicting Survival Outcome in Stage III Breast Cancer;Breast Cancer: Targets and Therapy;2023-10

5. FSCN1 as a new druggable target in adrenocortical carcinoma;International Journal of Cancer;2023-03-31